At the moment, patients with this genotype must rely on a drug combination involving interferon, with unpleasant side-effects for treatment. Epclusa costs nearly £39,000 for a 12-week course and ...

By contrast, the list price of hepatitis C drug Epclusa hasn't increased since it was approved in 2016. The Pharmaceutical Research and Manufacturers of America, a trade group representing drug ...

Gilead said it will launch the drug through a newly created subsidiary, Asegua Therapeutics. The low cost versions of Epclusa (sofosbuvir+velpatasvir) and Harvoni (ledipasvir+sofosbuvir ...